Casein kinase 1δ-IN-8

CAS No. 851396-73-1

Casein kinase 1δ-IN-8( —— )

Catalog No. M37072 CAS No. 851396-73-1

Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
10MG 100 In Stock
25MG 162 In Stock
50MG 241 In Stock
100MG 350 In Stock
500MG 795 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Casein kinase 1δ-IN-8
  • Note
    Research use only, not for human use.
  • Brief Description
    Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.
  • Description
    Casein kinase 1δ-IN-8 (compound 494) is an inhibitor of Casein kinase 1δ, Casein kinase 1δ-IN-8 can be used in the treatment of neurodegenerative disorders such as Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    Casein Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    851396-73-1
  • Formula Weight
    379.41
  • Molecular Formula
    C19H14FN5OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(CC(=O)C1=CC=CN1)C=2N(C(=NN2)C=3C=CN=CC3)C4=CC=C(F)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sheridan, Joseph M, et, al. Casein kinase 1δ inhibitors for the treatment of neurodegenerative disorders. WO2012080729 A2 2012-06-21.
molnova catalog
related products
  • ON108110

    ON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM).

  • CK2-IN-4

    CK2-IN-4 is a protein kinase (CK2) inhibitor with an IC50 value of 8.6 μM. CK2-IN-4 has potential anticancer ah and anti-inflammatory activity for the study of viral infections and glomerulonephritis diseases.

  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).